Sho Miyamoto

6PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Primary Small Cell Neuroendocrine Carcinoma of the Sublingual Gland Treated With Definitive Chemoradiotherapy: A Case Report.

|Sep 30, 2025
Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma.

Takahiro Iwamoto, Kazuhiro Ogi, Takafumi Nakagaki

|May 21, 2025
Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Sho Miyamoto, Azuna Osaki, Aiko Murai

|Sep 08, 2023
Physical Properties and Cellular Metabolic Characteristics of 3D Spheroids Are Possible Definitive Indices for the Biological Nature of Cancer-Associated Fibroblasts.

Nami Nishikiori, Kohichi Takada, Tatsuya Sato

|Jun 22, 2023
Three-Dimensional Spheroid Configurations and Cellular Metabolic Properties of Oral Squamous Carcinomas Are Possible Pharmacological and Pathological Indicators.

Sho Miyamoto, Nami Nishikiori, Tatsuya Sato

|Jun 22, 2023
Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy.

Sho Miyamoto, Yoshihiko Hirohashi, Rena Morita

Pageof 1

Frequent Collaborators

4 joint publications

Akihiro Miyazaki

3 joint publications

Kazuhiro Ogi

2 joint publications

Yoshihiko Hirohashi

2 joint publications

Takayuki Kanaseki